Quent Capital LLC Grows Holdings in Colgate-Palmolive (NYSE:CL)

Quent Capital LLC lifted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 17.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,213 shares of the company’s stock after buying an additional 621 shares during the quarter. Quent Capital LLC’s holdings in Colgate-Palmolive were worth $437,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of CL. Great Waters Wealth Management increased its stake in Colgate-Palmolive by 1.5% in the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock valued at $796,000 after purchasing an additional 117 shares during the last quarter. Seneca House Advisors purchased a new stake in Colgate-Palmolive in the 3rd quarter valued at about $209,000. Park Avenue Securities LLC increased its stake in shares of Colgate-Palmolive by 38.3% during the 3rd quarter. Park Avenue Securities LLC now owns 10,705 shares of the company’s stock valued at $1,111,000 after acquiring an additional 2,966 shares during the last quarter. Canandaigua National Bank & Trust Co. lifted its holdings in shares of Colgate-Palmolive by 1.8% during the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 12,122 shares of the company’s stock worth $1,258,000 after acquiring an additional 211 shares during the period. Finally, Czech National Bank boosted its position in shares of Colgate-Palmolive by 6.5% in the third quarter. Czech National Bank now owns 166,449 shares of the company’s stock worth $17,279,000 after acquiring an additional 10,106 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the sale, the insider now owns 5,146 shares of the company’s stock, valued at $529,729.24. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 43,490 shares of company stock valued at $4,486,063. Insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several research reports. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. UBS Group raised their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Stifel Nicolaus lifted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 22nd. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their target price for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Finally, Bank of America lifted their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $104.74.

Read Our Latest Report on CL

Colgate-Palmolive Stock Down 0.9 %

Shares of NYSE:CL opened at $99.04 on Friday. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $109.30. The company’s fifty day moving average is $103.65 and its two-hundred day moving average is $96.81. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The stock has a market capitalization of $81.26 billion, a price-to-earnings ratio of 31.34, a price-to-earnings-growth ratio of 3.62 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same period in the prior year, the firm earned $0.77 EPS. The business’s quarterly revenue was up 4.9% on a year-over-year basis. Equities analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.02%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.